drugset / Trial / NCT01531075
Hepatitis B Vaccine in Patients With Inflammatory Bowel Disease
RandomizedParallel-groupOpen-labelPrevention
Summary
The objective is to assess the efficacy of Hepatitis B Virus vaccination in a population of IBD patients treated with immunosuppressive medications.
Timeline
- Start
- 2012-04
- Primary completion
- 2015-08
- Completion
- 2016-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Engerix-B | Vaccine | 20 ug | — |
| Subject | Engerix-B | Vaccine | 1 ml | — |
| Subject | Sci-B-Vac | Vaccine | 10 ug/ml | — |
| Subject | Sci-B-Vac | Vaccine | 1 ml | — |